4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-15-002917
CIK 0001369786operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:41 PM ET
Size
4.5 KB
Accession
0001181431-15-002917
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Tax Payment
Common Stock
2015-02-18$27.22/sh−452$12,303→ 24,961 total
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:41 PM ET
- Size
- 4.5 KB